Gabelli & Co Investment Advisers’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-65,922	Closed	-$1.21M	–	522
2020 Q4	$1.21M	Buy	+65,922	New	+$1.2M	0.19%	99

Gabelli & Co Investment Advisers's CBMG Position: Q1 2021 in Review

Gabelli & Co Investment Advisers sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 65,922 shares — an estimated $1.21M sold.

Gabelli & Co Investment Advisers first reported a position in CBMG in Q4 2020 and held it in 1 quarter. The position peaked at $1.21M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Gabelli & Co Investment Advisers reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 65,922 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $1.21M.
Gabelli & Co Investment Advisers first reported a position in Cellular Biomedicine Group, Inc. in Q4 2020 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Cellular Biomedicine Group, Inc. position peaked at $1.21M in Q4 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2021, filed 14 May 2021.